封面
市场调查报告书
商品编码
1954096

日本诊断检测市场规模、份额、趋势及预测(按检测类型、技术、检体类型、检测方法、最终用户应用和地区划分),2026-2034年

Japan Diagnostic Testing Market Size, Share, Trends and Forecast by Test Type, Technology, Sample Type, Mode of Testing, Application End User, and Region, 2026-2034

出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 5-7个工作天内

价格
简介目录

日本诊断检测市场规模在2025年达到126亿美元。 IMARC集团预测,到2034年,该市场规模将达到192亿美元,2026年至2034年的复合年增长率(CAGR)为4.82%。医疗技术的进步、公众健康意识的提高以及慢性病盛行率的上升,正推动着该市场显着成长。分子诊断、影像诊断和就地检验领域的技术创新正在拓展市场机会。在完善的医疗基础设施和对早期诊断需求的推动下,预计该市场将进一步发展,并巩固其在日本诊断检测市场的份额。

日本诊断检测市场的发展趋势:

就地检验的需求日益增长

在日本,即时检测(POC​​)因其能够快速且方便地在患者所在之处提供诊断结果,正变得越来越普及。它特别适用于急诊室、诊所和居家医疗机构,在这些场所,快速且准确的结果有助于即时做出决策。日本不断增长的人口和老化也推动了对即时检测的需求,因为早期诊断和治疗至关重要。即时检测技术的进步,例如血糖值测量、妊娠检测和感染疾病检测,最大限度地缩短了患者和医护人员的等待时间,并提高了医疗效率。此外,即时检测的便利性减轻了医疗机构的负担,并促进了资源的合理利用。例如,2023年6月,希森美康公司宣布推出全球首个可在30分钟内检测抗菌药物敏感性的即时检测系统。该系统专为尿道感染设计,利用创新的微流体技术提供快速结果,优化抗生素的使用,并有助于解决抗菌药物抗药性(AMR)这一紧迫的全球性问题。随着日本致力于改善医疗保健服务并缓解医院拥挤状况,预计即时诊断工具市场将迅速扩张,并成为该国医疗保健基础设施的关键组成部分。

人工智慧(AI)集成

人工智慧(AI)正在改变日本的诊断检测市场,显着提升了检测结果解读的准确性、速度和效率。如今,人工智慧演算法已被整合到诊断设备中,使其能够比传统方法更有效地分析复杂数据。这在影像学、病理学和分子诊断等领域尤其重要,因为人工智慧可以快速识别人类临床医生可能忽略的模式和异常情况。人工智慧还能减少人为错误,确保更可靠的诊断并改善患者预后。例如,2025年1月,Monitor公司与DoctorNet合作,在日本推出了人工智慧肺癌诊断工具「MONCAD CTLN」。该软体可辅助放射科医师透过电脑断层扫描检测肺癌。鑑于日本放射科医师短缺,此次合作旨在加强人工智慧辅助诊断在医疗领域的应用。此外,人工智慧驱动的工具还能分析基因数据并提案个人化治疗方案,进而协助实现精准医疗。随着对人工智慧技术投入的不断增加,日本的医疗保健系统在疾病管理方面正变得更加积极和精准。人工智慧的持续整合有望极大地促进日本诊断测试市场的成长,推动创新并增加对人工智慧驱动的诊断解决方案的需求。

本报告解答的关键问题

  • 日本的诊断检测市场目前表现如何?未来几年又将如何发展?
  • 日本的诊断检测市场是如何依检测类型细分的?
  • 日本诊断检测市场按技术是如何细分的?
  • 日本诊断检测市场按检体类型分類的情况如何?
  • 日本诊断检测市场依检测方法分類的组成是怎样的?
  • 日本诊断检测市场按应用领域分類的市场区隔如何?
  • 日本诊断检测市场依最终用户分類的组成是怎样的?
  • 日本诊断检测市场按地区分類的组成是怎样的?
  • 日本诊断检测市场价值链的不同阶段有哪些?
  • 日本诊断检测市场的主要驱动因素和挑战是什么?
  • 日本诊断检测市场的结构是怎么样的?主要参与者有哪些?
  • 日本诊断检测市场的竞争程度如何?

目录

第一章:序言

第二章:调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章:日本诊断检测市场:简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章:日本诊断检测市场现状

  • 过去和当前的市场趋势(2020-2025)
  • 市场预测(2026-2034)

第六章:日本诊断检测市场-依检测类型细分

  • 实验室测试
  • 即时检测(POC​​T)
  • 影像诊断
  • 分子诊断
  • 其他的

第七章:日本诊断检测市场-依技术细分

  • 基于免疫检测法
  • 基于PCR的
  • 次世代定序
  • 基于光谱学
  • 基于层析法
  • 微流体技术
  • 其他的

第八章:日本诊断检测市场-依检体类型细分

  • 尿
  • 唾液
  • 头髮
  • 其他的

第九章 日本诊断检测市场-依检测方法细分

  • 处方笺测试
  • 市售测试

第十章:日本诊断测试市场(按应用领域划分)

  • 肿瘤学
  • 循环系统
  • 整形外科
  • 胃肠病学
  • 妇科
  • 神经病学
  • 牙科
  • 其他的

第十一章:日本诊断测试市场-按最终用户细分

  • 医院
  • 诊断中心
  • 门诊手术中心(ASC)
  • 专科诊所
  • 居家医疗
  • 血库
  • 研究机构和实验室
  • 其他的

第十二章:日本诊断检测市场区域划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十三章:日本诊断侦测市场:竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十四章主要企业简介

第十五章 日本诊断检测市场:产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十六章附录

简介目录
Product Code: SR112026A35217

The Japan diagnostic testing market size reached USD 12.6 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 19.2 Billion by 2034 , exhibiting a growth rate (CAGR) of 4.82 % during 2026-2034 . The market is witnessing significant growth driven by advances in medical technologies, increasing healthcare awareness, and rising prevalence of chronic diseases. Innovations in molecular diagnostics, imaging, and point-of-care testing are expanding market opportunities. With a strong healthcare infrastructure and demand for early diagnosis, the market is poised for significant developments, further solidifying Japan diagnostic testing market share.

JAPAN DIAGNOSTIC TESTING MARKET TRENDS:

Growing Demand of Point-of-Care Testing

Point-of-care (POC) testing is increasingly popular in Japan because it offers quicker, more convenient diagnostic results directly at the patient's site. The instruments prove especially useful in emergency rooms, clinics, and home care situations, providing speedy and accurate results that support immediate decision-making. Japan's population growth and increasing aging rate also fuel demand for POC testing, where early diagnosis and treatment are essential. With advances in technologies like instant blood glucose testing, pregnancy tests, and infection detection, the waits for patients and healthcare professionals are minimized and care efficiency increased. Additionally, the convenience offered by POC tests relieves healthcare facilities from the workload, and resource utilization is enhanced. For instance, in June 2023, Sysmex Corporation announced the launch of the world's first point-of-care testing system that detects antimicrobial susceptibility within 30 minutes. Designed for urinary tract infections, the system utilizes innovative microfluidic technology to provide rapid results, enhancing antimicrobial use and addressing the urgent global threat of antimicrobial resistance (AMR). As Japan focuses on improving healthcare accessibility and reducing hospital overcrowding, the POC diagnostic tools market is expected to expand rapidly, becoming a key part of the nation's healthcare infrastructure.

Integration of Artificial Intelligence

Artificial Intelligence (AI) is transforming the Japan diagnostic testing market by enhancing accuracy, speed, and efficiency in test result interpretation. AI algorithms are now being integrated into diagnostic devices, enabling them to analyze complex data more effectively than traditional methods. This is particularly beneficial in areas such as imaging, pathology, and molecular diagnostics, where AI can quickly identify patterns and anomalies that may be overlooked by human clinicians. AI also reduces the chances of human error, ensuring more reliable diagnoses and improving patient outcomes. For instance, in January 2025, Monitor Corporation announced the launch of its AI lung cancer diagnosis tool, MONCAD CTLN, in Japan through a partnership with Doctor-NET. The software aids radiologists in detecting lung cancer via CT scans. With Japan's radiologist shortage, this collaboration aims to enhance AI-assisted diagnostics in the healthcare sector. Moreover, AI-driven tools assist in personalized medicine by analyzing genetic data to recommend tailored treatment plans. With growing investment in AI technologies, Japan's healthcare system is becoming more proactive and precise in managing diseases. The continued integration of AI is expected to contribute significantly to the Japan diagnostic testing market growth, driving innovation and increasing demand for AI-powered diagnostic solutions.

JAPAN DIAGNOSTIC TESTING MARKET SEGMENTATION:

Test Type Insights:

  • Laboratory Testing
  • Point-of-Care Testing (POCT)
  • Imaging Diagnostics
  • Molecular Diagnostics
  • Others

Technology Insights:

  • Immunoassay-Based
  • PCR-Based
  • Next Gen Sequencing
  • Spectroscopy-Based
  • Chromatography-Based
  • Microfluidics

Sample Type Insights:

  • Blood
  • Urine
  • Saliva
  • Sweat
  • Hair

Mode of Testing Insights:

  • Prescription Based Testing
  • OTC Testing

Application Insights:

  • Oncology
  • Cardiology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Neurology
  • Odontology

End User Insights:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Homecare
  • Blood Banks
  • Research Labs and Institutes

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan diagnostic testing market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan diagnostic testing market on the basis of test type?
  • What is the breakup of the Japan diagnostic testing market on the basis of technology?
  • What is the breakup of the Japan diagnostic testing market on the basis of sample type?
  • What is the breakup of the Japan diagnostic testing market on the basis of mode of testing?
  • What is the breakup of the Japan diagnostic testing market on the basis of application?
  • What is the breakup of the Japan diagnostic testing market on the basis of end user?
  • What is the breakup of the Japan diagnostic testing market on the basis of region?
  • What are the various stages in the value chain of the Japan diagnostic testing market?
  • What are the key driving factors and challenges in the Japan diagnostic testing market?
  • What is the structure of the Japan diagnostic testing market and who are the key players?
  • What is the degree of competition in the Japan diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Diagnostic Testing Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Diagnostic Testing Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Diagnostic Testing Market - Breakup by Test Type

  • 6.1 Laboratory Testing
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Point-of-Care Testing (POCT)
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Imaging Diagnostics
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Molecular Diagnostics
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan Diagnostic Testing Market - Breakup by Technology

  • 7.1 Immunoassay-Based
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 PCR-Based
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Next Gen Sequencing
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Spectroscopy-Based
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Chromatography-Based
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Microfluidics
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2020-2025)
    • 7.7.2 Market Forecast (2026-2034)

8 Japan Diagnostic Testing Market - Breakup by Sample Type

  • 8.1 Blood
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Urine
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Saliva
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Sweat
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Hair
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2020-2025)
    • 8.6.2 Market Forecast (2026-2034)

9 Japan Diagnostic Testing Market - Breakup by Mode of Testing

  • 9.1 Prescription Based Testing
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 OTC Testing
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)

10 Japan Diagnostic Testing Market - Breakup by Application

  • 10.1 Oncology
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Cardiology
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Orthopedics
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Gastroenterology
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Forecast (2026-2034)
  • 10.5 Gynecology
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Forecast (2026-2034)
  • 10.6 Neurology
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Forecast (2026-2034)
  • 10.7 Odontology
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Forecast (2026-2034)
  • 10.8 Others
    • 10.8.1 Historical and Current Market Trends (2020-2025)
    • 10.8.2 Market Forecast (2026-2034)

11 Japan Diagnostic Testing Market - Breakup by End User

  • 11.1 Hospitals
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Forecast (2026-2034)
  • 11.2 Diagnostic Center
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Forecast (2026-2034)
  • 11.3 Ambulatory Surgical Centers (ASCs)
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Forecast (2026-2034)
  • 11.4 Specialty Clinics
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Forecast (2026-2034)
  • 11.5 Homecare
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Forecast (2026-2034)
  • 11.6 Blood Banks
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Forecast (2026-2034)
  • 11.7 Research Labs and Institutes
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Forecast (2026-2034)
  • 11.8 Others
    • 11.8.1 Historical and Current Market Trends (2020-2025)
    • 11.8.2 Market Forecast (2026-2034)

12 Japan Diagnostic Testing Market - Breakup by Region

  • 12.1 Kanto Region
    • 12.1.1 Overview
    • 12.1.2 Historical and Current Market Trends (2020-2025)
    • 12.1.3 Market Breakup by Test Type
    • 12.1.4 Market Breakup by Technology
    • 12.1.5 Market Breakup by Sample Type
    • 12.1.6 Market Breakup by Mode of Testing
    • 12.1.7 Market Breakup by Application
    • 12.1.8 Market Breakup by End User
    • 12.1.9 Key Players
    • 12.1.10 Market Forecast (2026-2034)
  • 12.2 Kansai/Kinki Region
    • 12.2.1 Overview
    • 12.2.2 Historical and Current Market Trends (2020-2025)
    • 12.2.3 Market Breakup by Test Type
    • 12.2.4 Market Breakup by Technology
    • 12.2.5 Market Breakup by Sample Type
    • 12.2.6 Market Breakup by Mode of Testing
    • 12.2.7 Market Breakup by Application
    • 12.2.8 Market Breakup by End User
    • 12.2.9 Key Players
    • 12.2.10 Market Forecast (2026-2034)
  • 12.3 Central/ Chubu Region
    • 12.3.1 Overview
    • 12.3.2 Historical and Current Market Trends (2020-2025)
    • 12.3.3 Market Breakup by Test Type
    • 12.3.4 Market Breakup by Technology
    • 12.3.5 Market Breakup by Sample Type
    • 12.3.6 Market Breakup by Mode of Testing
    • 12.3.7 Market Breakup by Application
    • 12.3.8 Market Breakup by End User
    • 12.3.9 Key Players
    • 12.3.10 Market Forecast (2026-2034)
  • 12.4 Kyushu-Okinawa Region
    • 12.4.1 Overview
    • 12.4.2 Historical and Current Market Trends (2020-2025)
    • 12.4.3 Market Breakup by Test Type
    • 12.4.4 Market Breakup by Technology
    • 12.4.5 Market Breakup by Sample Type
    • 12.4.6 Market Breakup by Mode of Testing
    • 12.4.7 Market Breakup by Application
    • 12.4.8 Market Breakup by End User
    • 12.4.9 Key Players
    • 12.4.10 Market Forecast (2026-2034)
  • 12.5 Tohoku Region
    • 12.5.1 Overview
    • 12.5.2 Historical and Current Market Trends (2020-2025)
    • 12.5.3 Market Breakup by Test Type
    • 12.5.4 Market Breakup by Technology
    • 12.5.5 Market Breakup by Sample Type
    • 12.5.6 Market Breakup by Mode of Testing
    • 12.5.7 Market Breakup by Application
    • 12.5.8 Market Breakup by End User
    • 12.5.9 Key Players
    • 12.5.10 Market Forecast (2026-2034)
  • 12.6 Chugoku Region
    • 12.6.1 Overview
    • 12.6.2 Historical and Current Market Trends (2020-2025)
    • 12.6.3 Market Breakup by Test Type
    • 12.6.4 Market Breakup by Technology
    • 12.6.5 Market Breakup by Sample Type
    • 12.6.6 Market Breakup by Mode of Testing
    • 12.6.7 Market Breakup by Application
    • 12.6.8 Market Breakup by End User
    • 12.6.9 Key Players
    • 12.6.10 Market Forecast (2026-2034)
  • 12.7 Hokkaido Region
    • 12.7.1 Overview
    • 12.7.2 Historical and Current Market Trends (2020-2025)
    • 12.7.3 Market Breakup by Test Type
    • 12.7.4 Market Breakup by Technology
    • 12.7.5 Market Breakup by Sample Type
    • 12.7.6 Market Breakup by Mode of Testing
    • 12.7.7 Market Breakup by Application
    • 12.7.8 Market Breakup by End User
    • 12.7.9 Key Players
    • 12.7.10 Market Forecast (2026-2034)
  • 12.8 Shikoku Region
    • 12.8.1 Overview
    • 12.8.2 Historical and Current Market Trends (2020-2025)
    • 12.8.3 Market Breakup by Test Type
    • 12.8.4 Market Breakup by Technology
    • 12.8.5 Market Breakup by Sample Type
    • 12.8.6 Market Breakup by Mode of Testing
    • 12.8.7 Market Breakup by Application
    • 12.8.8 Market Breakup by End User
    • 12.8.9 Key Players
    • 12.8.10 Market Forecast (2026-2034)

13 Japan Diagnostic Testing Market - Competitive Landscape

  • 13.1 Overview
  • 13.2 Market Structure
  • 13.3 Market Player Positioning
  • 13.4 Top Winning Strategies
  • 13.5 Competitive Dashboard
  • 13.6 Company Evaluation Quadrant

14 Profiles of Key Players

  • 14.1 Company A
    • 14.1.1 Business Overview
    • 14.1.2 Services Offered
    • 14.1.3 Business Strategies
    • 14.1.4 SWOT Analysis
    • 14.1.5 Major News and Events
  • 14.2 Company B
    • 14.2.1 Business Overview
    • 14.2.2 Services Offered
    • 14.2.3 Business Strategies
    • 14.2.4 SWOT Analysis
    • 14.2.5 Major News and Events
  • 14.3 Company C
    • 14.3.1 Business Overview
    • 14.3.2 Services Offered
    • 14.3.3 Business Strategies
    • 14.3.4 SWOT Analysis
    • 14.3.5 Major News and Events
  • 14.4 Company D
    • 14.4.1 Business Overview
    • 14.4.2 Services Offered
    • 14.4.3 Business Strategies
    • 14.4.4 SWOT Analysis
    • 14.4.5 Major News and Events
  • 14.5 Company E
    • 14.5.1 Business Overview
    • 14.5.2 Services Offered
    • 14.5.3 Business Strategies
    • 14.5.4 SWOT Analysis
    • 14.5.5 Major News and Events

15 Japan Diagnostic Testing Market - Industry Analysis

  • 15.1 Drivers, Restraints, and Opportunities
    • 15.1.1 Overview
    • 15.1.2 Drivers
    • 15.1.3 Restraints
    • 15.1.4 Opportunities
  • 15.2 Porters Five Forces Analysis
    • 15.2.1 Overview
    • 15.2.2 Bargaining Power of Buyers
    • 15.2.3 Bargaining Power of Suppliers
    • 15.2.4 Degree of Competition
    • 15.2.5 Threat of New Entrants
    • 15.2.6 Threat of Substitutes
  • 15.3 Value Chain Analysis

16 Appendix